Defence Therapeutics Statistics

Total Valuation

CSE:DTC has a market cap or net worth of CAD 50.45 million. The enterprise value is 51.10 million.

Market Cap	50.45M
Enterprise Value	51.10M

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:DTC has 57.33 million shares outstanding. The number of shares has increased by 15.72% in one year.

Current Share Class	57.33M
Shares Outstanding	57.33M
Shares Change (YoY)	+15.72%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	3.96%
Owned by Institutions (%)	n/a
Float	55.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-35.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.08

Financial Position

The company has a current ratio of 0.93

Current Ratio	0.93
Quick Ratio	0.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.70
Interest Coverage	-14.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-129.42%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-59,152.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.04% in the last 52 weeks. The beta is 1.34, so CSE:DTC's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	+66.04%
50-Day Moving Average	0.82
200-Day Moving Average	0.85
Relative Strength Index (RSI)	55.91
Average Volume (20 Days)	88,159

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.31M
Pretax Income	-3.62M
Net Income	-3.62M
EBITDA	-3.27M
EBIT	-3.31M
Earnings Per Share (EPS)	-0.07

Full Income Statement

Balance Sheet

The company has 2.32 million in cash and 2.97 million in debt, giving a net cash position of -649,752 or -0.01 per share.

Cash & Cash Equivalents	2.32M
Total Debt	2.97M
Net Cash	-649,752
Net Cash Per Share	-0.01
Equity (Book Value)	-1.41M
Book Value Per Share	-0.03
Working Capital	-186,943

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.21 million and capital expenditures -21,114, giving a free cash flow of -4.23 million.

Operating Cash Flow	-4.21M
Capital Expenditures	-21,114
Free Cash Flow	-4.23M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:DTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.72%
Shareholder Yield	-15.72%
Earnings Yield	-7.17%
FCF Yield	-8.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1